Uncategorized
Nicox submits new drug application for AC-170
Nicox has submitted a new drug application to the FDA for AC-170 to treat ocular itching associated with allergic conjunctivitis, according to a press release. The company also requested a priority review based on clinical pediatric data generated with AC-170, a cetirizine eye drop formulation.